U-M Rogel Cancer Center

What U-M Rogel Cancer Center does

The U-M Rogel Cancer Center is the National Cancer Institute-designated comprehensive cancer center within the University of Michigan Health System, a nonprofit academic medical enterprise headquartered in Ann Arbor, Michigan and governed by the Regents of the University of Michigan. It delivers multidisciplinary cancer care across more than two dozen specialized adult and pediatric clinics covering surgery, medical oncology, radiation oncology, immunotherapy, CAR T-cell therapy, bone marrow and cellular transplantation, precision oncology, theranostics, genetic counseling, cancer rehabilitation, fertility preservation, and survivorship programs, supported by patient and family support services and a nurse-staffed Cancer AnswerLine. The center is consistently rated #1 in Michigan by U.S. News & World Report, and its faculty participate as members of the National Comprehensive Cancer Network, helping shape national treatment guidelines.

Its underlying "technology" is a coordinated clinical-research-education platform rather than a software product: an integrated care delivery stack anchored on disease-specific multidisciplinary clinics, an institutional clinical trials infrastructure, and a translational research pipeline spanning gene-editing (e.g., Mats Ljungman's Ewing sarcoma program), chromatin-remodeling oncology (Parolia Lab), and hereditary cancer cascade testing in collaboration with Stanford University.

Revenue is generated through three primary streams: (1) patient care services billed through insurance and patient payments across U-M Health, (2) federal and foundation research grants (notably the NCI, Alex's Lemonade Stand Foundation, and the Little Warrior Foundation), and (3) philanthropic donations channeled through community events such as Swim Across America, the Rose Run, and various golf outings. Patient acquisition runs primarily through physician referrals via MLine (800-962-3555), direct appointment scheduling (734-647-8902), and community outreach, with a statewide radiation oncology network broadening regional access. Pricing is not publicly disclosed because services are contractually negotiated through insurance and institutional billing inside a nonprofit academic system.

Name

U-M Rogel Cancer Center

Legal name

University of Michigan Health Rogel Cancer Center

Website

https://rogelcancercenter.org

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Short description

The U-M Rogel Cancer Center is an NCI-designated comprehensive cancer center within the University of Michigan Health System in Ann Arbor, delivering multidisciplinary adult and pediatric oncology care, clinical trials, and cancer research funded by grants and philanthropy.

Ownership category

akta.pro rank

Product category

Cancer Care and Oncology Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Outpatient Care Centers (6214)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Pediatric Specialty Care Centers (e.g., cardiology, oncology, neurology) (HLAFAJAH)

Keywords

• Cancer care services
• Oncology treatment
• Clinical trials research
• Radiation oncology
• Precision medicine

Headquarters

HQ city

Ann Arbor

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Care Services: Revenue generated from direct patient care services including consultations, treatments, surgeries, and clinical procedures. Healthcare services are billed through insurance and patient payments.
2. Research Grants: Federal and foundation funding for cancer research programs including NCI grants, Alex's Lemonade Stand Foundation awards, and other philanthropic funding for specific research projects.
3. Philanthropic Donations: Charitable contributions from donors supporting cancer research, patient programs, and facility enhancements. Events like Swim Across America and various golf outings raise funds.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

U-M Rogel Cancer Center is an NCI-designated Comprehensive Cancer Center within the University of Michigan Health System that delivers multidisciplinary cancer diagnosis, treatment, and supportive care across more than two dozen specialty clinics for both adult and pediatric oncology patients. It also conducts laboratory, translational, and clinical research, and operates education and community outreach programs including a free nurse-staffed Cancer AnswerLine helpline.

Product overview

The Rogel Cancer Center is a comprehensive cancer center (NCI-designated) operating as part of University of Michigan Health. It provides a unified platform of cancer care comprising patient care services, research programs, and education. The center offers more than 2 dozen specialized clinics and programs including multidisciplinary cancer care, pediatric oncology programs (Blood and Marrow Transplant, Brain Tumors, Neuroblastoma, Leukemia, Lymphoma, Sarcomas), precision oncology, CAR T-cell therapy, radiation oncology with statewide network, transplantation and cellular therapy, and theranostics. Support services include the Patient and Family Support Services Program, Cancer AnswerLine (free nurse-staffed helpline), Cancer Genetics programs, fertility preservation, and rehabilitation. Research programs span basic science, clinical trials, and community outreach. The online genetic risk sharing tool and Parolia Lab research program represent recent initiatives in patient-facing technology and pediatric cancer precision medicine.

Differentiator

Problem solved

Functional benefit

Products and services

• Rogel Cancer Center NCI-designated comprehensive cancer center providing multidisciplinary adult and pediatric oncology care, cancer research, and education programs; rated #1 cancer program in Michigan by U.S. News & World Report.
• Multidisciplinary Cancer Care Coordinated cancer care with specialists from multiple disciplines working together on personalized treatment plans for adult and pediatric patients.
• Clinical Trials for Cancer Patients Access to novel treatments and research studies for cancer patients through clinical trial participation across multiple disease areas.
• Radiation Oncology Radiation therapy services including external beam radiation, internal radiation (brachytherapy), and advanced radiotherapy technologies for cancer treatment, delivered through a statewide network.
• CAR T-cell Therapy Advanced cellular immunotherapy using genetically engineered T cells to treat eligible cancer patients, including children, as part of the broader transplantation and cellular therapy program.
• Transplantation and Cellular Therapy Program Blood and marrow transplantation and cellular therapy services for cancer treatment, including pediatric blood and marrow transplant and pediatric cellular therapy.
• Theranostics Program Targeted radiopharmaceutical diagnostic and therapeutic services combining imaging and therapy for cancer patients.
• Pediatric Cancer Program Comprehensive cancer care program for infants, children, and adolescents with disease-specific specialty clinics including leukemia, brain tumors, neuroblastoma, lymphoma, bone and soft tissue sarcomas, germ cell tumors, hepatoblastoma, melanoma, Wilms tumor, rhabdomyosarcoma, plus cellular therapy, BMT, precision oncology, and HIPEC surgical capability.
• Adolescent and Young Adult (AYA) Oncology Program Specialized oncology program focused on the unique cancer care needs of adolescents and young adults, bridging pediatric and adult oncology services.
• Breast Cancer Care Comprehensive breast cancer program including detection, surgery, chemotherapy, radiation, metastatic care, and supportive services with sub-programs for fertility, older adults, sexual health, and hereditary cancer.
• Lung Cancer Program Multidisciplinary lung cancer care program providing screening, diagnosis, treatment, and supportive care.
• Liver Cancer Program Comprehensive liver cancer diagnosis, treatment, and research program for adult and pediatric (hepatoblastoma) patients.
• Pancreatic Cancer Comprehensive pancreatic cancer diagnosis, treatment, and research program.
• Sarcoma Program Comprehensive sarcoma program for adult and pediatric patients, including multidisciplinary sarcoma care with multiple specialty collaboration and bone sarcoma specialty services.
• Cancer Genetics Genetic counseling and testing program for hereditary cancer risk assessment, including a dedicated Cancer Genetics & Breast Health Program.
• Fertility Preservation Program for Cancer Patients Services to preserve fertility options for cancer patients before treatment begins.
• Cancer Rehabilitation Program Rehabilitation services to help cancer patients recover function and quality of life during and after treatment, including cardio-oncology care for treatment-related heart effects.
• Patient and Family Support Services Program Non-clinical supportive care including complementary and creative therapies such as art therapy, music therapy, counseling, and the Patient and Family Advisory Council for cancer patients and families.
• Cancer AnswerLine Free community service staffed by nurses to answer questions about cancer, available Monday through Friday 8 a.m. to 4:30 p.m. at 800-865-1125.
• Multidisciplinary Brain Tumor Clinic Team-based approach to brain tumor care involving multiple specialists, with a parallel dedicated pediatric brain tumor program for diagnosis, treatment, and research.
• Cardio-Oncology Clinic Specialized clinic addressing heart health for cancer patients and survivors, managing treatment-related cardiotoxicity.
• Childhood Cancer Survivorship Program Long-term follow-up care and support program for childhood cancer survivors.
• Pediatric Precision Oncology Program Personalized cancer treatment using genetic and molecular profiling for pediatric patients.
• Relapsed and Resistant Pediatric Cancer Program Specialized program for treating pediatric cancers that have returned or are resistant to standard treatments.
• HIPEC for Pediatric Cancer Hyperthermic intraperitoneal chemotherapy surgical treatment for pediatric cancers.
• MyHPVscore Test HPV testing service for cervical cancer screening and risk assessment.
• Online Genetic Risk Sharing Tool Online tool that assists cancer patients in sharing genetic risk information with their families.
• Parolia Lab Research Program Research program at the Rogel Cancer Center focused on developing precision treatments for Ewing sarcoma using SWI/SNF chromatin remodeling activity in preclinical models, supported by an $800,000 'A' Award from Alex's Lemonade Stand Foundation.

Quantifiable outcome

• #1 Cancer Program in Michigan per U.S. News & World Report

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Stanford UniversitycoreStrategic or Co-development PartnerCollaborating institution on the $3.2 million NCI grant for cascade genetic testing research. Joint research team spanning both institutions.
• National Comprehensive Cancer NetworkcoreStrategic or Co-development PartnerRogel Cancer Center faculty participate in setting national guidelines for cancer care as members of the NCCN.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Roswell Park Comprehensive Cancer Center: One of the original NCI-designated Comprehensive Cancer Centers with deep clinical-trial and translational research programs. Comparable to Rogel as a full-spectrum academic oncology enterprise offering inpatient, outpatient, and research services.
• Northwestern Medicine Robert H. Lurie Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center within a major Big Ten-affiliated academic medical center. Closely mirrors Rogel's model of embedding oncology research and multidisciplinary care inside a flagship Midwestern academic health system.
• University of Chicago Medicine Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center based at a Midwest academic medical center. Comparable to Rogel in structure, NCI designation, and Midwest-academic positioning with deep subspecialty programs.

Broad incumbents

• City of Hope Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center with a national reputation in transplantation, cellular therapy, and precision oncology. Directly comparable to Rogel on CAR T-cell, BMT, and precision oncology capabilities.
• Mayo Clinic Comprehensive Cancer Center: NCI-designated comprehensive cancer program within a major nonprofit academic health system. Comparable to Rogel in offering integrated specialty oncology services inside a broader multispecialty academic medical center.
• Cleveland Clinic Taussig Cancer Institute: Large nonprofit multispecialty academic-style cancer program operating within a national health system. Comparable to Rogel in providing complex oncology care as part of a multi-state integrated delivery network.
• MD Anderson Cancer Center: The largest freestanding NCI-designated Comprehensive Cancer Center in the U.S. and a global leader in oncology care and research. Most directly comparable to Rogel in scope, NCI designation, and academic-research depth.
• Dana-Farber Cancer Institute: Harvard-affiliated NCI-designated Comprehensive Cancer Center with leading research and clinical programs across adult and pediatric oncology. Comparable to Rogel in academic-research model and subspecialty clinic structure.
• Fred Hutchinson Cancer Center: Seattle-based NCI-designated Comprehensive Cancer Center renowned for bone marrow transplantation and immunotherapy research. Directly comparable to Rogel's transplantation and CAR T-cell programs.
• Memorial Sloan Kettering Cancer Center: A premier NCI-designated Comprehensive Cancer Center focused exclusively on oncology with deep research, clinical trials, and subspecialty programs. Comparable to Rogel in multidisciplinary depth and pediatric-adult oncology breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/UMRogelCancer
• LinkedInlinkedin.com/company/rogel-cancer-center

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about U-M Rogel Cancer Center